CJC-1295 DAC 5mg

CJC-1295 DAC 5mg is a long-acting research peptide widely studied for its role in growth hormone (GH) release and hormonal regulation pathways. As a modified analog of growth hormone-releasing hormone (GHRH), CJC-1295 with DAC (Drug Affinity Complex) is designed to extend the peptide’s half-life, allowing for sustained stimulation of growth hormone and IGF-1 levels in research settings.

This compound is commonly explored in studies related to muscle growth, recovery, fat metabolism, and overall endocrine function. Its extended activity makes it particularly valuable for researchers investigating long-term hormonal signaling and the effects of consistent GH elevation on body composition and metabolic processes.

CJC-1295 DAC is frequently used in research models focusing on protein synthesis, tissue repair, sleep regulation, and aging-related pathways, as growth hormone plays a central role in many physiological functions. Its long-lasting profile distinguishes it from shorter-acting peptides, providing a more stable and prolonged response in experimental conditions.

This product is supplied as a 99%+ pure lyophilized powder, with 5mg per vial, ensuring high quality and consistency for laboratory research. It should be stored at 2°C to 4°C (refrigerated) and handled using proper laboratory protocols to maintain stability and effectiveness.

CJC-1295 DAC 5mg is intended strictly for research purposes only. It is not for human consumption, medical use, or diagnostic applications.